source
- Drugmakers have to go through rigorous tests to get a lower tariff rateLanding a reduced 20% tariff rate will require pharma companies to fill out extensive paperwork and be closely monitored by the Department of Commerce. President Donald Trump signed an executive or…Endpoints · 2mo ago↗ source
- Dana-Farber Study Finds Stage IV Breast Cancer Increasing in Incidence and Proportion Over the Last DecadeA Dana-Farber study showed cases of stage IV breast cancer are increasing in incidence and as a proportion of all breast cancer diagnoses.onclive · 2mo ago↗ source
- Degron, CREATE, TenNor raise capital; Cabaletta posts CAR-T data💸 A Series A extension: US-China biotech Degron Therapeutics has collected an additional $40 million for its molecular glue degrader platform. The San Diego and Shanghai biotech has raised $95 mil…